New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 7, 2012
09:08 EDTAET, ABMD, SWHC, AMRN, BAGL, HWDOn The Fly: Pre-market Movers
HIGHER AFTER EARNINGS: Smith & Wesson (SWHC), up 3.9%... ALSO HIGHER: Einstein Noah (BAGL), up 8.9% after declaring $4.00 special dividend... Aetna (AET), up 1.2% after JPMorgan upgrades to Overweight... LOWER AFTER EARNINGS: Harry Winston (HWD), down 2.9%... ALSO LOWER: Amarin (AMRN), down 19.1% after announcing non-equity financing, saying continues to assess strategic alternatives... ABIOMED (ABMD), down 5.8% after an FDA panel voted to retain Class III status for certain pumps, including its Impella.
News For AET;BAGL;SWHC;HWD;AMRN;ABMD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 21, 2014
16:36 EDTAETMarket ends week higher as domestic data, foreign central banks boost shares
Subscribe for More Information
14:27 EDTAETAetna raises quarterly dividend 11%, authorizes additional $1B share buyback
Subscribe for More Information
14:26 EDTAETAetna raises quarterly dividend 11%, authorizes additional $1B share buyback
Subscribe for More Information
November 19, 2014
15:00 EDTAMRNStonepine Capital reports 5.2% passive stake in Amarin
07:09 EDTABMDJefferies to hold a conference
2014 Global London Healthcare Conference is being held in London, England on November 19-20.
November 17, 2014
09:06 EDTAMRNAmarin reports new data from MARINE, ANCHOR phase 3 studies
Amarin announced the presentation of new data and related analyses from the MARINE and ANCHOR phase 3 studies. The data show that use of Vascepa capsules significantly reduced remnant-like particle cholesterol, or RLP-C, levels -- a cardiovascular risk factor -- including significant placebo-adjusted reductions in RLP-C in studied patient populations with triglyceride, or TG, levels greater than or equal to 200 mg/dL and greater than or equal to 500 mg/dL, including patients that received statin therapy. The data were presented today by Dr. Christie M. Ballantyne as part of a moderated poster session at the American Heart Association Scientific Sessions in Chicago. Remnant-like particle cholesterol is an important emerging risk factor for cardiovascular disease and represents the cholesterol content of a subset of triglyceride-rich lipoproteins, or TRL, called remnants. In the fasting state this subset of TRLs is comprised of very low-density lipoproteins, or VLDL, and intermediate-density lipoproteins, or IDL, and in the non-fasting state includes these two types of lipoproteins together with chylomicron remnants.Elevated plasma TG levels are a marker of elevated remnant cholesterol and are associated with increased risk for cardiovascular disease.
07:16 EDTAETMilken Institute--Faster Cures to hold a conference
Subscribe for More Information
November 12, 2014
08:58 EDTAETManaged Care earnings risk low from King vs. Burwell, says Leerink
Leerink believes the Supreme Court decision to the King vs. Burwell case carries low earnings risk for Managed Care companies. The case to determine the legality of Exchange subsidies administered by the Federal Government carries less than 2% and 3% of earnings risk for 2014 and 2015 estimates, respectively, Leerink believes. The firm says Humana (HUM) and Cigna (CI) are currently losing money on Exchanges, and thus could benefit from any Federal Exchange membership loss. Leerink lists Aetna (AET), Centene (CNC), WellPoint (WLP) and Molina Healthcare (MOH) as being most impacted.
08:02 EDTAETCredit Suisse to hold a conference
Subscribe for More Information
07:55 EDTAETAetna to reaffirm FY14 operating EPS view $6.60-$6.70, consensus $6.68
Subscribe for More Information
November 11, 2014
12:55 EDTAETWorkarounds to likely protect insurers from Supreme Court decision, says Wedbush
Subscribe for More Information
November 10, 2014
10:06 EDTAETAetna selected for new Louisiana Medicaid contract
Aetna Better Health of Louisiana, an Aetna health plan established to administer managed Medicaid services in Louisiana, has been selected by the State Department of Health & Hospitals to provide access to health care for eligible Louisianans. The three-year contract is scheduled to take effect Feb. 1, 2015.
08:46 EDTAETAetna price target raised to $99 from $90 at Jefferies
Jefferies raised its price target for Aetna shares to $99 after meeting with management and keeps a Buy rating on the stock. The firm believes Aetna's 2015 earnings growth can top the consensus of 10%.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use